• OPEN AN ACCOUNT
Indian Indices
Nifty
22,336.40 189.40
(0.86%)
Sensex
73,811.97 163.35
( 0.22%)
Bank Nifty
47,924.90 350.75
( 0.74%)
Nifty IT
33,538.80 170.50
( 0.51%)
Global Indices
Nasdaq
15,451.31 169.30
(1.11%)
Dow Jones
38,239.98 253.58
(0.67%)
Hang Seng
16,511.69 287.55
(1.77%)
Nikkei 225
37,552.16 113.55
(0.30%)
Forex
USD-INR
83.42 -0.13
(-0.16%)
EUR-INR
88.89 -0.20
(-0.23%)
GBP-INR
103.18 -0.89
(-0.85%)
JPY-INR
0.54 0.00
(-0.29%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
320.5640364
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
33.25
109341.46
EPS(TTM)
Face Value()
Div & Yield %
40.73
2
0.63
 

cipla ltd
Cipla to divest its entire 51% stake in Saba Investment, UAE
May 16,2023
Cipla has entered into a binding term sheet to sell its entire stake of 51% held in Saba Investment, UAE (Saba) to Shibam Group Holding, UAE.

Consequent to the sale, upon executionof the transaction, Saba and its subsidiaries viz Cipla Middle East Pharmaceuticals FZ LLC, UAE (CME) and Cipla Medica Pharmaceutical and Chemical Industries, Yemen (Cipla Medica), will cease to be subsidiaries of the Company.